Erschienen in:

01.03.2023 | Case report

Glycopyrrolate/phenylephrine

Refractory hypertension following drug interaction and exposure during delivery: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Auszug

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon; Drug interaction

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Bansal V, et al. Refractory hypertension after phenylephrine infusion in cesarean section under subarachnoid block. Saudi Journal of Anaesthesia 17: 107-109, No. 1, 2023. Available from: URL: http://doi.org/10.4103/sja.sja_461_22

Titel: Glycopyrrolate/phenylephrine
Refractory hypertension following drug interaction and exposure during delivery: case report
Publikationsdatum: 01.03.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-35776-3

Sertraline

Case report

Dexmedetomidine

Case report

Covid-19-vaccine-pfizer-biontech

Case report

Warfarin

Case report

BRAF and MEK inhibitor combination therapy-related eye AEs

Clinical study

Etoposide/mogamulizumab

Case report

Springer Medizin

Glycopyrrolate/phenylephrine

Refractory hypertension following drug interaction and exposure during delivery: case report

Auszug

Weitere Artikel der Ausgabe 1/2023

Sertraline

Dexmedetomidine

Covid-19-vaccine-pfizer-biontech

Warfarin

BRAF and MEK inhibitor combination therapy-related eye AEs

Etoposide/mogamulizumab

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sertraline

Dexmedetomidine

Covid-19-vaccine-pfizer-biontech

Warfarin

BRAF and MEK inhibitor combination therapy-related eye AEs

Etoposide/mogamulizumab